Plasmid DNA Manufacturing Market Companies

  • Report ID: 6369
  • Published Date: Mar 19, 2025
  • Report Format: PDF, PPT

Companies dominating the Plasmid DNA Manufacturing Landscape

    The plasmid DNA manufacturing market has a strong competitive landscape globally with a dynamic and diverse eco-system comprising well-established players such as GenScript ProBio, Samsung Biologics, and emerging players, including WuXi Biologics, Fujifilm Diosynth Biotechnologies, and Hanmi Fine Chemical. The National Institute of Advanced Industrial Science and Technology and A*STAR Bioprocessing Technology are two research institutes that are substantially contributing to the advancements within the market. Start-ups, such as GeneTech and PlasmidFactory, are introducing novel solutions to the market.

    Furthermore, the market is enhanced by the regional presence of global businesses, including Lonza and Thermo Fisher Scientific. The plasmid DNA manufacturing market is growing and innovation in this eco-system, is propelled by partnerships, rise in the focus on regenerative medicine, and investments in advanced technologies.

    Some of the major players are:

    • VGXI, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • JAFRAL Ltd.
    • Luminous Biosciences
    • Delphi Genetics
    • Akron Biotech
    • Plasmidfactory GmbH
    • Cobra Biologics & Pharmaceutical Services
    • Vigene Biosciences
    • Aldevron
    • Nature Technology Corporation

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Currently in 2025, the industry revenue of plasmid DNA manufacturing is estimated at USD 2.57 billion.

The global plasmid DNA manufacturing market is set to expand from USD 2.24 billion in 2024 to USD 26.13 billion by 2037, registering a CAGR of more than 20.8% during the forecast timeline, from 2025 through 2037.

North America industry is poised to account for largest revenue share of 42% by 2037, driven by its strong research and development and technological infrastructure in the region.

The major players in the market include JAFRAL, Ltd., Delphi Genetics, Aldevron, VGXI, Inc., and Akron Biotech are some prominent companies in the plasmid DNA manufacturing market.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos
GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

See our insights in action - schedule your demo now!

Live Sample Reading